- Home
- BHR vs ACRV Comparison
BHR vs ACRV Comparison
Compare BHR & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHR
- ACRV
- Stock Information
- Founded
- BHR 2013
- ACRV 2018
- Country
- BHR United States
- ACRV United States
- Employees
- BHR N/A
- ACRV N/A
- Industry
- BHR Real Estate Investment Trusts
- ACRV Medicinal Chemicals and Botanical Products
- Sector
- BHR Real Estate
- ACRV Health Care
- Exchange
- BHR Nasdaq
- ACRV Nasdaq
- Market Cap
- BHR 209.5M
- ACRV 170.3M
- IPO Year
- BHR N/A
- ACRV 2022
- Fundamental
- Price
- BHR $2.61
- ACRV $5.65
- Analyst Decision
- BHR Hold
- ACRV Strong Buy
- Analyst Count
- BHR 1
- ACRV 5
- Target Price
- BHR $2.50
- ACRV $22.40
- AVG Volume (30 Days)
- BHR 357.0K
- ACRV 50.9K
- Earning Date
- BHR 02-26-2025
- ACRV 11-13-2024
- Dividend Yield
- BHR 7.71%
- ACRV N/A
- EPS Growth
- BHR N/A
- ACRV N/A
- EPS
- BHR N/A
- ACRV N/A
- Revenue
- BHR $732,339,000.00
- ACRV N/A
- Revenue This Year
- BHR N/A
- ACRV N/A
- Revenue Next Year
- BHR N/A
- ACRV N/A
- P/E Ratio
- BHR N/A
- ACRV N/A
- Revenue Growth
- BHR N/A
- ACRV N/A
- 52 Week Low
- BHR $1.79
- ACRV $3.19
- 52 Week High
- BHR $3.95
- ACRV $11.90
- Technical
- Relative Strength Index (RSI)
- BHR 33.17
- ACRV 41.71
- Support Level
- BHR $2.45
- ACRV $5.36
- Resistance Level
- BHR $2.75
- ACRV $6.00
- Average True Range (ATR)
- BHR 0.15
- ACRV 0.52
- MACD
- BHR -0.03
- ACRV -0.01
- Stochastic Oscillator
- BHR 20.25
- ACRV 17.74
About BHR Braemar Hotels & Resorts Inc.
Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury, upper-upscale and upscale hotels in gateway and resort locations. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and Renaissance, among others.
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.